These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Efficacy, safety and potential clinical roles of the COX-2-specific inhibitors. van der Bijl P; van der Bijl P Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):17-22. PubMed ID: 14552700 [TBL] [Abstract][Full Text] [Related]
13. Targeting cyclooxygenase-2 in human neoplasia: rationale and promise. Dannenberg AJ; Subbaramaiah K Cancer Cell; 2003 Dec; 4(6):431-6. PubMed ID: 14706335 [No Abstract] [Full Text] [Related]
14. Prostaglandins and other metabolites of arachidonic acid. An overview for the otolaryngologist. Poole MD; Pillsbury HC Arch Otolaryngol; 1985 May; 111(5):317-21. PubMed ID: 2985036 [TBL] [Abstract][Full Text] [Related]
15. Prostaglandins and leukotrienes: advances in eicosanoid biology. Funk CD Science; 2001 Nov; 294(5548):1871-5. PubMed ID: 11729303 [TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2: a therapeutic target. Turini ME; DuBois RN Annu Rev Med; 2002; 53():35-57. PubMed ID: 11818462 [TBL] [Abstract][Full Text] [Related]
17. [Clinical pharmacology of selective inhibitors of cyclooxygenase-2]. Patrignani P Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):13-8, 37-40. PubMed ID: 15058604 [No Abstract] [Full Text] [Related]
18. Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis. Ajuebor MN; Singh A; Wallace JL Am J Physiol Gastrointest Liver Physiol; 2000 Jul; 279(1):G238-44. PubMed ID: 10898767 [TBL] [Abstract][Full Text] [Related]